R Bhole, K Chadar, Y Zambare… - İstanbul Journal of …, 2019 - dergipark.org.tr
Background: Dofetilide is the class III antiarrhythmic drug used as a potassium channel
blocker approved by US FDA in 1999 for the maintenance of sinus rhythm in individuals …